There are no sets in this subject.
No groups found.
| memantine definitions | |||
|---|---|---|---|
| # | Definition | Sets | |
| 1 | namenda | 15 sets | |
| 2 | antipsychotic: alzheimer | 2 sets | |
| 3 | alzheimer's treatment, nmda receptor agonist | 2 sets | |
| 4 | n-methyl-d-aspartate receptor antagonist | 2 sets | |
| 5 | neuroprotector, inhibit nmda receptor at pcp site weakly | 2 sets | |
| 6 | -weak (low affinity binding to pcp binding site) non-competitive inhibitors of nmda glutamate receptors | 1 set | |
| 7 | alzheimer's/dementia tx | 1 set | |
| 8 | nmda receptor antagonist | 1 set | |
| 9 | spasmolytics, neuropprotective; weak -pcp on nmda, noncompetitive, block excessive opening of ca+2 channel; tx: alz | 1 set | |
| 10 | alzheimer's agent | 1 set | |
| 11 | namenda:: nmda receptor antagonist, alzheimer's dementia | 1 set | |
| 12 | a drug that acts as an uncompetitive inhibitor to prevent nmda excitotoxicity (too much ca++ in the cell). it blocks the nmda pore at low membrane potentials, but is removed when the channel should be active. | 1 set | |
| 13 | nameda | 1 set | |
| 14 | namemda | 1 set | |
| 15 | 5, 10mg daily | 1 set | |
| 16 | nmda receptor antagonist, memory loss | 1 set | |
| 17 | namenda n-methyl-d-aspartate receptor antagonist alzheimer's dementia | 1 set | |
| 18 | treatment of moderate-to-severe dementia | 1 set | |
| 19 | namenda, nmda receptor antagonist, alzheimer's dementia | 1 set | |
| 20 | treatment of moderate to severe dementia of alzheimer's type | 1 set | |
| 21 | nmda receptor agonist | 1 set | |
| 22 | alzheimer's dementia | 1 set | |
| 23 | namenda/n-methyl-d-aspartate receptor antagonist | 1 set | |
| 24 | alzheimer's treatment; nmda receptor agonist | 1 set | |
| 25 | nmda receptor antagonist, alzheimers | 1 set | |
| 26 | mechanism: nmda receptor antagonist, helps prevent excitotoxicity; clinical: alzheimers; se: dizziness, confusion, hallucinations | 1 set | |